Sanuwave Health Gross Profit 2012-2026 | SNWV
Sanuwave Health gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Sanuwave Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $34 |
| 2024 | $25 |
| 2023 | $14 |
| 2022 | $12 |
| 2021 | $8 |
| 2020 | $3 |
| 2019 | $0 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $1 |
| 2015 | $1 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $1 |
| 2011 | $1 |
|
Sanuwave Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-06-30 | $7 |
| 2026-03-31 | $7 |
| 2025-12-31 | $10 |
| 2025-09-30 | $9 |
| 2025-06-30 | $8 |
| 2025-03-31 | $7 |
| 2024-12-31 | $8 |
| 2024-09-30 | $7 |
| 2024-06-30 | $5 |
| 2024-03-31 | $4 |
| 2023-12-31 | $5 |
| 2023-09-30 | $4 |
| 2023-06-30 | $3 |
| 2023-03-31 | $3 |
| 2022-12-31 | $4 |
| 2022-09-30 | $3 |
| 2022-06-30 | $3 |
| 2022-03-31 | $2 |
| 2021-12-31 | $3 |
| 2021-09-30 | $2 |
| 2021-06-30 | $2 |
| 2021-03-31 | $1 |
| 2020-12-31 | $2 |
| 2020-09-30 | $1 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.036B | $0.044B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |